These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1325101)

  • 1. Antiviral effects of herpes simplex virus specific anti-sense nucleic acids.
    Cantin EM; Podsakoff G; Willey DE; Openshaw H
    Adv Exp Med Biol; 1992; 312():139-49. PubMed ID: 1325101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5.
    Kulka M; Wachsman M; Miura S; Fishelevich R; Miller PS; Ts'o PO; Aurelian L
    Antiviral Res; 1993 Feb; 20(2):115-30. PubMed ID: 8384823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline.
    Sekizawa T; Openshaw H; Itoyama Y
    J Med Virol; 2003 Jun; 70(2):263-6. PubMed ID: 12696114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection.
    Hoke GD; Draper K; Freier SM; Gonzalez C; Driver VB; Zounes MC; Ecker DJ
    Nucleic Acids Res; 1991 Oct; 19(20):5743-8. PubMed ID: 1658742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary oligonucleotide sequence inhibits both Vmw65 gene expression and replication of herpes simplex virus.
    Draper KG; Ceruzzi M; Kmetz ME; Sturzenbecker LJ
    Antiviral Res; 1990 Apr; 13(4):151-64. PubMed ID: 2166465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mouse hepatitis virus multiplication by antisense oligonucleotide, antisense RNA, sense RNA and ribozyme.
    Mizutani T; Hayashi M; Maeda A; Sasaki N; Yamashita T; Kasai N; Namioka S
    Adv Exp Med Biol; 1993; 342():129-35. PubMed ID: 8209719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 2 growth and latency reactivation by cocultivation are inhibited with antisense oligonucleotides complementary to the translation initiation site of the large subunit of ribonucleotide reductase (RR1).
    Aurelian L; Smith CC
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):77-85. PubMed ID: 10805158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.
    Smith CC; Aurelian L; Reddy MP; Miller PS; Ts'o PO
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2787-91. PubMed ID: 3010316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense RNA directed to the human papillomavirus type 16 E7 mRNA from herpes simplex virus type 1 derived vectors is expressed in CaSki cells and downregulates E7 mRNA.
    Kari I; Syrjänen S; Johansson B; Peri P; He B; Roizman B; Hukkanen V
    Virol J; 2007 Jun; 4():47. PubMed ID: 17547759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved anti-herpes simplex virus type 1 activity of a phosphodiester antisense oligonucleotide containing a 3'-terminal hairpin-like structure.
    Poddevin B; Meguenni S; Elias I; Vasseur M; Blumenfeld M
    Antisense Res Dev; 1994; 4(3):147-54. PubMed ID: 7849485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture.
    Schnitzler P; Schön K; Reichling J
    Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression.
    Guzman EM; Cheshenko N; Shende V; Keller MJ; Goyette N; Juteau JM; Boivin G; Vaillant A; Herold BC
    Antivir Ther; 2007; 12(8):1147-56. PubMed ID: 18240855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
    Zaia JA; Chatterjee S; Wong KK; Elkins D; Taylor NR; Rossi JJ
    Ann N Y Acad Sci; 1992 Oct; 660():95-106. PubMed ID: 1340161
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of herpes simplex virus replication by antisense oligo-2'-O-methylribonucleoside methylphosphonates.
    Kean JM; Kipp SA; Miller PS; Kulka M; Aurelian L
    Biochemistry; 1995 Nov; 34(45):14617-20. PubMed ID: 7578069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I. Effect on cell growth, virus particles and virus replication.
    Dargan DJ; Subak-Sharpe JH
    J Gen Virol; 1985 Aug; 66 ( Pt 8)():1771-84. PubMed ID: 2991440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new promising candidate to overcome drug resistant herpes simplex virus infections.
    Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
    Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
    Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SV40 gene expression by microinjected small antisense RNA and DNA molecules.
    Graessmann M; Michaels G; Berg B; Graessmann A
    Nucleic Acids Res; 1991 Jan; 19(1):53-8. PubMed ID: 1849259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.